Highlights of Ophthalmology

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  52 (2024)
Volume  51 (2023)
Volume  50 (2022)
Volume  49 (2021)
Volume  48 (2020)
Volume  47 (2019)
Volume  46 (2018)
Volume  45 (2017)
Volume  44 (2016)
Volume  43 (2015)
Volume  42 (2014)
Volume  41 (2013)
Volume  40 (2012)
Volume  39 (2011)
Volume  38 (2009)
Related articles

VOLUME 44 , ISSUE 1ENG ( Feb-2016, 2016 ) > List of Articles

Antibiotic Prophylaxis on the Conjunctival Flora of Patients Receiving Intravitreal Antivascular Endothelial Growth Factor Injections

Maria Picoto Passarinho, Joana R. Portelinha, Teresa J. Pacheco, António E. Rodrigues, Teresa P. Marques, Fernanda F. Vaz

Citation Information : Passarinho MP, Portelinha JR, Pacheco TJ, Rodrigues AE, Marques TP, Vaz FF. Antibiotic Prophylaxis on the Conjunctival Flora of Patients Receiving Intravitreal Antivascular Endothelial Growth Factor Injections. 2016; 44 (1ENG):2-10.

DOI: 10.5005/highlights-44-1-2

Published Online: 28-01-2021

Copyright Statement:  Copyright © 2016; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract
PDF Share
  1. Moss JM, Stanislo SR, Ta C: Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections. Ophthalmology 2010; 117: 2141-2145.
  2. Harry WF, Charles CW, Philip JR: Antiseptics vs antibiotics for intravitreal injections. Subspeciality Day 2011: Retina.
  3. Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC: Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology 2012; 119: 1609-1614.
  4. Moshirfar M, Feiz V, Vitale AT, Wegelin JA, Basavanthappa S, Wolsey DH: Endophthalmitis after uncomplicated cataract surgery with the use of fourthgeneration fluoroquinolones: a retrospective observational case series. Ophthalmology 2007; 114: 686-691.
  5. Speaker MG, Menikoff JA: Prophylaxis of endophthalmitis with topical povidoneiodine. Ophthalmology 1991;98: 1769-1775.
  6. Halachmi-Eyal O, Lang Y, Keness Y, Miron D: Preoperative topical moxifloxacin 0,5% and povidone-iodine 5,0% versus povidone-iodine 5,0% alone to reduce bacterial colonization in the conjunctival sac. J Cataract Refract Surg 2009; 35: 1609-1613.
  7. Hyon JY, Eser I, O'Brien TP: Kill rates of preserved and preservation-free topical 8-methoxy fluoroquinolones against various strains of Staphylococcus. J Cataract Refract Surg 2009; 35: 1609-1613.
  8. Bhavsar AR, Ip MS, Glassman AR; DRCRnet Study Group, SCORE Study Group: The risk of endophthalmitis following intravitreal triamcinolone injection in the DRCRnet and SCORE clinical trials. Am J Ophthalmol 2007;144: 454-456.
  9. Bhavsar AR, Googe JM Jr, Stockdale CR, Bressler NM, Brucker AJ, Elman MJ, Glassman AR; Diabetic Retinopathy Clinical Research Network: Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the Diabetic Retinopathy Clinical Research Network Laser-Ranibizumab-Triamcinolone Clinical Trials. Arch Ophthalmol 2009; 127: 1581-1583.
  10. Bhatt SS, Stepien KE, Joshi K: Prophylactic antibiotic use after intravitreal injection: effect on endophthalmitis rate. Retina 2011; 31: 2032-2036.
  11. Ta CN, Egbert PR, Singh K, Shriver EM, Blumenkranz MS, Miño De Kaspar H: Prospective randomized comparison of 3-day versus 1-hour preoperative ofloxacin prophylaxis for cataract surgery. Ophthalmology 2002; 109: 2036-2040.
  12. Moss JM, Sanislo SR, Ta CN: A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 2009; 116: 1498-1501.
  13. Jager RD, Aiello LP, Patel SC, Cunningham ET: Risks of intravitreous injection: a comprehensive review. Retina 2004; 24: 676-698.
  14. Moss JM, Nguyen D, Liu YI, Singh K, Montague A, Egbert PR, Kaspar HM, Ta CN: Comparison of one-day versus one-hour application of topical gatifloxacin in eliminating conjunctival bacterial flora. Ophthalmology 2008;115: 2013-2016.
  15. Ta CN, He L, Mino de Kaspar H: In vitro antibiotic susceptibility of preoperative normal conjunctival bacteria. Eye (Lond) 2009; 23: 559-560.
  16. Green-Simms AE, Ekdawi NS, Bakri SJ: Survey of intravitreal injection techniques among retinal specialists in the United States. Am J Ophthalmol 2011; 151: 329-332.
  17. Kim SJ, Toma HS, Midha NK, Cherney EF, Recchia FM, Doherty TJ: Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections. Ophthalmology 2010; 117: 2372-2378.
  18. Han DP, Wisniewski SR, Wilson LA, Barza M, Vine AK, Doft BH, Kelsey SF: Spectrum and susceptibilities of microbiological isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 1996; 122: 1-17.
  19. Bannerman TL, Rhoden DL, McAllister SK, Miller JM, Wilson LA: The source of coagulase negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsedfield gel electrophoresis. Arch Ophthalmol 1997; 115: 357-361.
  20. Moss JM, Sanislo SR, Ta CN: Antibiotic susceptibility patterns of ocular bacterial flora in patients undergoing intravitreal injections. Ophthalmology 2010; 117: 2141-2145.
  21. Hatch WV, Cernat G, Wong D, Devenyi R, Bell CM: Risk factors for acute endophthalmitis after cataract surgery: a population-based study. Ophthalmology 2009; 116: 425-430.
  22. Fintak DR, Ho AC: Perioperative and operative considerations in diabetics. Ophthalmol Clin North Am 2006;19: 427-434.
  23. Holz EH: Reducing endophthalmitis risk factors: where we stand. Am J Ophthalmol 2005; 139: 1097-1098.
  24. Ou JI, Ta CN: Endophthalmitis prophylaxis. Ophthalmol Clin North Am 2006; 19: 449-456.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.